Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Hopital de Hautpierre, Université de Strasbourg, Strasbourg, France.
HPB (Oxford). 2014 Jan;16(1):46-55. doi: 10.1111/hpb.12063. Epub 2013 Mar 6.
A pancreatic fistula (PF) is the most relevant complication after a pancreaticoduodenectomy (PD). This retrospective multicentric study attempts to elucidate the risk factors and complications of a PF in a large cohort of patients undergoing a PD for ductal adenocarcinoma.
Using a survey tool, clinical data of 1325 patients undergoing a PD for ductal adenocarcinoma at 37 institutions, between January 2004 and December 2009, were collected. Peri-operative risk factors associated with PF and its association with morbidity and mortality were assessed. Morbidity and PF were graded according to the ISGPF (International Study group for pancreatic fistula) definition and the Dindo-Clavien classification.
Overall PF, mortality, morbidity and relaparotomy rates were 14.3%, 3.8%, 54.4% and 11.7%, respectively. PF occurred more frequently after a pancreaticojejunostomy (PJ) compared with a pancreaticogastrostomy (PG) (16.8% vs. 10.4%; P = 0.0012). Independent risk factors for PF by multivariate analysis were absence of pre-operative diabetes (P = 0.0014), PJ reconstruction (P = 0.0035), soft pancreatic parenchyma (P < 0.0001) and low-volume centre (P = 0.0286). Clinically relevant PF (grade B and C) and severe complications (Dindo-Clavien grade IIIB, IV, V) were significantly more frequent after PJ than PG (71.6% vs. 28.3%; P = 0.030 and 24.8% vs. 19.1%; P = 0.015, respectively). Overall mortality and relaparotomy rates were similar after PG and PJ.
A soft pancreatic parenchyma, the absence of pre-operative diabetes, PJ and low-volume centre are independent risk factors for PF after PD for ductal adenocarcinoma. A significantly higher incidence and clinical severity of PF are associated with PJ.
胰瘘(PF)是胰十二指肠切除术(PD)后最相关的并发症。本回顾性多中心研究试图阐明在接受 PD 治疗导管腺癌的大患者队列中 PF 的风险因素和并发症。
使用调查工具,收集了 2004 年 1 月至 2009 年 12 月期间 37 家机构的 1325 例接受 PD 治疗导管腺癌的患者的临床数据。评估了与 PF 相关的围手术期风险因素及其与发病率和死亡率的关系。根据 ISGPF(国际胰腺瘘研究组)定义和 Dindo-Clavien 分类对发病率和 PF 进行分级。
总的 PF、死亡率、发病率和再次剖腹率分别为 14.3%、3.8%、54.4%和 11.7%。胰肠吻合术(PJ)后 PF 的发生率明显高于胰胃吻合术(PG)(16.8%比 10.4%;P = 0.0012)。多因素分析显示,PF 的独立危险因素包括术前无糖尿病(P = 0.0014)、PJ 重建(P = 0.0035)、胰腺质地柔软(P < 0.0001)和低容量中心(P = 0.0286)。PJ 后临床相关的 PF(等级 B 和 C)和严重并发症(Dindo-Clavien 等级 IIIB、IV 和 V)的发生率明显高于 PG(71.6%比 28.3%;P = 0.030 和 24.8%比 19.1%;P = 0.015)。PG 和 PJ 后总的死亡率和再次剖腹率相似。
胰腺质地柔软、术前无糖尿病、PJ 和低容量中心是 PD 治疗导管腺癌后 PF 的独立危险因素。PJ 后 PF 的发生率和临床严重程度明显更高。